Kai Medtech
PrivateLast Round
Series D
Jul 27, 2026
Est. Valuation
$500M
Total Funding Raised
$118M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Kai Medtech is a medical device company that specializes in the research, development, production, and sale of neuro-interventional and implantable medical devices for cerebrovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kai Medtech Comparables
Compare Kai Medtech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wallaby Medical | 87% | |
| Conmind Medical | 85% | |
| Zylox-Tonbridge Medical Technology Co., Ltd. | 85% |
For institutional investors. Book with your work email.
Kai Medtech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 27, 2026 | ||||
| Series C | Jan 5, 2024 | ||||
| Series B Extension | Mar 16, 2022 | ||||
| Series B | Aug 1, 2021 |
For institutional investors. Book with your work email.
Kai Medtech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hengxu Capital | Series B Extension, Series B |
| Wuxi Capital Group Co.,Ltd | Series C |
| Shanghai Sci-tech Capital | Series D |
| Huatai Zijin Investment | Series D |
| ICBC Capital Management Co., Ltd. | Series D |
| TF Capital | Series B |
| 高瓴创投 | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
$70M round led by Shanghai Sci-tech Capital.
- Jan 5, 2024
Raised Series C round with Wuxi Capital Group Co.,Ltd.
For institutional investors. Book with your work email.
Kai Medtech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kai Medtech's valuation, stock price, and market status.
Is Kai Medtech a public or private company?
Kai Medtech is a private company.
What is the current stock price of Kai Medtech?
Kai Medtech is a private company, so its shares have no public market price. Caplight tracks Kai Medtech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kai Medtech worth (valuation)?
Kai Medtech's valuation is estimated at $500.0M based on funding round data.
Can I buy Kai Medtech stock?
Kai Medtech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kai Medtech's last funding round?
Kai Medtech's most recent funding round was Series D on July 27, 2026.
Who are the main investors in Kai Medtech?
Key investors in Kai Medtech include Hengxu Capital, Shanghai Sci-tech Capital, Shenzhen Capital Group.
Will Kai Medtech IPO soon?
No public IPO plans have been announced for Kai Medtech.
How can I track Kai Medtech secondary market activity?
Caplight tracks bids, offers, and trades in Kai Medtech's shares on secondary markets.